These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 10850969)

  • 1. Inability to induce hypertension in normotensive rat expressing AT(1) receptor antisense.
    Pachori AS; Wang H; Gelband CH; Ferrario CM; Katovich MJ; Raizada MK
    Circ Res; 2000 Jun; 86(11):1167-72. PubMed ID: 10850969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic control of high blood pressure in the spontaneously hypertensive rat by delivery of angiotensin type 1 receptor antisense.
    Iyer SN; Lu D; Katovich MJ; Raizada MK
    Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9960-5. PubMed ID: 8790439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Permanent cardiovascular protection from hypertension by the AT(1) receptor antisense gene therapy in hypertensive rat offspring.
    Reaves PY; Gelband CH; Wang H; Yang H; Lu D; Berecek KH; Katovich MJ; Raizada MK
    Circ Res; 1999 Nov; 85(10):e44-50. PubMed ID: 10559146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin I-converting enzyme antisense gene therapy causes permanent antihypertensive effects in the SHR.
    Wang H; Reaves PY; Gardon ML; Keene K; Goldberg DS; Gelband CH; Katovich MJ; Raizada MK
    Hypertension; 2000 Jan; 35(1 Pt 2):202-8. PubMed ID: 10642298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of hypertension by angiotensin II type 1 receptor antisense gene therapy in the adult SHR.
    Katovich MJ; Gelband CH; Reaves P; Wang HW; Raizada MK
    Am J Physiol; 1999 Sep; 277(3):H1260-4. PubMed ID: 10484448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial-independent prevention of high blood pressure in L-NAME-treated rats by angiotensin II type I receptor antisense gene therapy.
    Reaves PY; Beck CR; Wang HW; Raizada MK; Katovich MJ
    Exp Physiol; 2003 Jul; 88(4):467-73. PubMed ID: 12861333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Losartan versus gene therapy: chronic control of high blood pressure in spontaneously hypertensive rats.
    Lu D; Raizada MK; Iyer S; Reaves P; Yang H; Katovich MJ
    Hypertension; 1997 Sep; 30(3 Pt 1):363-70. PubMed ID: 9314418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II type 1 receptor antisense gene therapy prevents altered renal vascular calcium homeostasis in hypertension.
    Gelband CH; Reaves PY; Evans J; Wang H; Katovich MJ; Raizada MK
    Hypertension; 1999 Jan; 33(1 Pt 2):360-5. PubMed ID: 9931130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of cold-induced hypertension by antisense oligodeoxynucleotides to angiotensinogen mRNA and AT1-receptor mRNA in brain and blood.
    Peng JF; Kimura B; Fregly MJ; Phillips MI
    Hypertension; 1998 Jun; 31(6):1317-23. PubMed ID: 9622148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated blood pressure in normotensive rats produced by 'knockdown' of the angiotensin type 2 receptor.
    Wang H; Gallinat S; Li HW; Sumners C; Raizada MK; Katovich MJ
    Exp Physiol; 2004 May; 89(3):313-22. PubMed ID: 15123567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antisense inhibition of brain renin-angiotensin system decreased blood pressure in chronic 2-kidney, 1 clip hypertensive rats.
    Kagiyama S; Varela A; Phillips MI; Galli SM
    Hypertension; 2001 Feb; 37(2 Pt 2):371-5. PubMed ID: 11230302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood pressure-independent attenuation of cardiac hypertrophy by AT(1)R-AS gene therapy.
    Pachori AS; Numan MT; Ferrario CM; Diz DM; Raizada MK; Katovich MJ
    Hypertension; 2002 May; 39(5):969-75. PubMed ID: 12019278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained inhibition of angiotensin I-converting enzyme (ACE) expression and long-term antihypertensive action by virally mediated delivery of ACE antisense cDNA.
    Wang H; Katovich MJ; Gelband CH; Reaves PY; Phillips MI; Raizada MK
    Circ Res; 1999 Oct; 85(7):614-22. PubMed ID: 10506486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of renovascular and cardiac pathophysiological changes in hypertension by angiotensin II type 1 receptor antisense gene therapy.
    Martens JR; Reaves PY; Lu D; Katovich MJ; Berecek KH; Bishop SP; Raizada MK; Gelband CH
    Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2664-9. PubMed ID: 9482944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II-induced renal vasoconstriction in genetic hypertension.
    Jackson EK; Herzer WA; Vyas SJ; Kost CK
    J Pharmacol Exp Ther; 1999 Oct; 291(1):329-34. PubMed ID: 10490921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pressor and renal hemodynamic effects of the novel angiotensin A peptide are angiotensin II type 1A receptor dependent.
    Yang R; Smolders I; Vanderheyden P; Demaegdt H; Van Eeckhaut A; Vauquelin G; Lukaszuk A; Tourwé D; Chai SY; Albiston AL; Nahmias C; Walther T; Dupont AG
    Hypertension; 2011 May; 57(5):956-64. PubMed ID: 21464395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphodiesterase 5 inhibition ameliorates angiotensin II-dependent hypertension and renal vascular dysfunction.
    Thieme M; Sivritas SH; Mergia E; Potthoff SA; Yang G; Hering L; Grave K; Hoch H; Rump LC; Stegbauer J
    Am J Physiol Renal Physiol; 2017 Mar; 312(3):F474-F481. PubMed ID: 28052870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrovirus-mediated transfer of an angiotensin type I receptor (AT1-R) antisense sequence decreases AT1-Rs and angiotensin II action in astroglial and neuronal cells in primary cultures from the brain.
    Lu D; Yu K; Raizada MK
    Proc Natl Acad Sci U S A; 1995 Feb; 92(4):1162-6. PubMed ID: 7862653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure.
    Levy BI; Benessiano J; Henrion D; Caputo L; Heymes C; Duriez M; Poitevin P; Samuel JL
    J Clin Invest; 1996 Jul; 98(2):418-25. PubMed ID: 8755652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term ANG II produces renal vasoconstriction independent of TP receptor activation and TxA2/isoprostane production.
    Vågnes ØB; Iversen BM; Arendshorst WJ
    Am J Physiol Renal Physiol; 2007 Sep; 293(3):F860-7. PubMed ID: 17567934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.